FDA Names First Medical Director for Emerging and Pandemic Threat Preparedness in the Center for Biologics Evaluation and Research
The Food and Drug Administration (FDA) today announced the appointment of Mark Goldberger, MD, MPH, as Medical Director for Emerging and Pandemic Threat Preparedness in FDA's Center for Biologics Evaluation and Research (CBER).